Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III ...

Genentech’s short film draws on the experiences of multiple families caring for children with hemophilia A, seeking to ...

Genentech will close its cancer immunology research department, and unit head and renowned cell biologist Ira Mellman, who has been with the company for 17 years, will depart in the coming months.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall ...

June 30 (Reuters) - Genentech will withdraw Gavreto from use in the United States for treating a type of thyroid cancer as it was not feasible for the Roche (ROG.S), opens new tab unit to pursue ...

Genentech, where Stanford President Marc Tessier-Lavigne once served as chief scientific officer, confirmed on Thursday that there were concerns about Alzheimer’s research Tessier-Lavigne co ...

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get ...

Repertoire Immune Medicines has signed a partnership and licensing agreement with Roche’s Genentech, focusing on the discovery and development of T cell-targeted immune medicines for treating an ...

You can reach Jonathan on Signal at jwosen.27. For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have ...

The company will establish a new 700,000-square-foot, high-volume fill-finish operation in Wake County to support its existing product portfolio as well as its future pipeline, allowing Genentech ...